High Dose of Inhaled Fluticasone Reduces High Levels of Urinary Leukotriene E4 in the Early Morning in Mild and Moderate Nocturnal Asthma

Chest

Volumn 124, Issue 5, 2003, Pages 1768-1773

  Tanaka, Shintaro ^a   Tanaka, Hiroshi ^a   Abe, Shosaku ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Circadian rhythm; Inhaled corticosteroid; Leukotriene; Nocturnal asthma

Indexed keywords

11 DEHYDRO THROMBOXANE BETA2; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE E4; THROMBOXANE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NOCTURNAL ASTHMA; PATIENT SELECTION; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; PROTEIN URINE LEVEL; URINARY EXCRETION; URINE LEVEL;

EID: 0242721238     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.124.5.1768     Document Type: Article

References (33)

1. 4, and histamine in normal human subjects. Thorax 1984; 39:500-504
2. 4 in normal and asthmatic subjects. Am Rev Respir Dis 1987; 135:333-337
3. 4 from the urine of patients with airway obstruction. Am Rev Respir Dis 1992; 146:104-108
4. Wenzel SE, Trudeau JB, Kaminsky DA, et al. Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma. Am J Respir Crit Care Med 1995; 152:897-905
5. 2 biosynthesis in acute asthma and after antigen challenge. Am Rev Respir Dis 1991; 143:119-125
6. 2 and prostacyclin. Stroke 1992; 23:1400-1403
7. Hetzel MR, Clark TJH. Comparison of normal and asthmatic circadian rhythms in peak expiratory flow rate. Thorax 1980; 35:732-738
8. Turner-Warwick M. Epidemiology of nocturnal asthma. Am J Med 1988; 85(Suppl 1B):6-8
9. 4 and histamine excretion rates in normal subjects and patients with mild-to-moderate asthma. J Allergy Clin Immunol 1995; 96:643-651
10. 4 in the assessment of nocturnal asthma. J Allergy Clin Immunol 1996; 97:735-741
11. 4 in healthy subjects and nocturnal asthmatic patients. Chest 2001; 120:1822-1828
12. Martin RJ, Cicutto LC, Smith HR, et al. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991; 143:351-357
13. Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996; 154:1505-1510
14. 4 excretion. Am Rev Respir Dis 1993; 147:1472-1476
15. Manso G, Baker AJ, Taylor IK, et al. In vivo and in vitro effects of glucocorticosteroids on arachidonic acid metabolism and monocyte function in nonasthmatic humans. Eur Respir J 1992; 5:712-716
16. Dworski R, Fitzgerald GA, Oates JA, et al. Effect of oral prednisone on airway inflammatory mediators in atopic asthma. Am J Respir Crit Care Med 1994; 149:953-959
17. 4 levels in patients during an asthmatic attack. Prostaglandins Leukot Essent Fatty Acids 1990; 40:285-289
18. Tsang KW, Ho PL, Lam WK, et al. Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. Am J Respir Crit Care Med 1998; 158:723-727
19. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136:225-244
20. Kraft M, Martin RJ, Susan M, et al. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999; 159:228-234
21. National Heart Lung and Blood Institute. Global initiative for asthma: global strategy for asthma management and prevention; NHLBI/WHO workshop report. Bethesda, MD: National Institutes of Health, 2002; Publication No. 02-3659
22. 4 to 2, 3-dinor-6-ketoprostaglandin (PG) F1 α. Allergy 1999; 54:489-494
23. 4 elimination and metabolism in man. J Allergy Clin Immunol 1990; 85:3-9
24. Wenzel SE, Szefler SJ, Leung DYM, et al. Bronchoscopic evaluation of severe asthma: persistent inflammation associated with high dose glucocorticoids. Am J Respir Crit Care Med 1997; 156:737-743
25. Jatakanon A. Neutrophilic inflammation in severe persistent asthma. Am J Respir Crit Care Med 1999; 160:1532-1539
26. Korenblat PE, Kemp JP, Scherger JE, et al. Effect of age on response to zafirlukast in patients with asthma in the Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT). Ann Allergy Asthma Immunol 2000; 84:217-225
27. 4 in rats. Am J Respir Crit Care Med 1995; 151:1143-1150
28. 4 production by alveolar macrophages from patients with nocturnal asthma. J Allergy Clin Immunol 1994; 94:870-881
29. 4 excretion in patients with rheumatoid arthritis. Prostaglandins Leukot Essent Fatty Acids 2001; 65:301-306
30. Hancox RJ, Stevens DA, Adcock IM, et al. Effects of inhaled beta agonist and corticosteroid treatment on nuclear transcription factors in bronchial mucosa in asthma. Thorax 1999; 54:488-492
31. Ray A, Prefontaine KE. Physical association and functional antagonism between the p65 subunit of transcription factor NFkB and glucocorticoid receptor. Proc Natl Acad Sci U S A 1994; 91:752-756
32. Adcock IM, Shirasaki H, Gelder CM, et al. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci 1994; 55:1147-1153
33. Wilson SJ, Wallin A, Della-Cioppa G, et al. Effects of budesonide and formoterol on NF-κB, adhesion molecules, and cytokines in asthma. Am J Respir Crit Care Med 2001; 164:1047-1052